1. Non‐coding and coding genomic variants distinguish prostate cancer, castration‐resistant prostate cancer, familial prostate cancer, and metastatic castration‐resistant prostate cancer from each other
    Ibrahim O. Alanazi et al, 2019, Molecular Carcinogenesis CrossRef
  2. MicroRNA profiling in the dentate gyrus in epileptic rats
    Suya Zhang et al, 2017, Medicine CrossRef
  3. BCL6 BTB‐specific inhibitor reversely represses T‐cell activation, Tfh cells differentiation, and germinal center reaction in vivo
    Yanhui CAI et al, 2021, European Journal of Immunology CrossRef
  4. The Profile of microRNA Expression in Diffuse Large B-Cell Lymphoma
    Yu. A. Veryaskina et al, 2023, Молекулярная биология CrossRef
  5. Homoharringtonine suppresses imatinib resistance via the Bcl-6/p53 pathway in chronic myeloid leukemia cell lines
    Qian Wang et al, 2017, Oncotarget CrossRef
  6. miR-187-3p participates in contextual fear memory formation through modulating SATB2 expression in the hippocampus
    Cui Zhao et al, 2020, NeuroReport CrossRef
  7. MiR-187 regulates the proliferation, migration and invasion of human trophoblast cells by repressing BCL6-mediated activation of PI3K/AKT signaling
    Xin Chen et al, 2022, Placenta CrossRef
  8. CiRS-187 regulates BMPR2 expression by targeting miR-187 in bovine cumulus cells treated with BMP15 and GDF9
    Yao Fu et al, 2023, Theriogenology CrossRef
  9. MicroRNA Expression Profiling of Diffuse Large B-Cell Lymphoma
    Yu. A. Veryaskina et al, 2023, Molecular Biology CrossRef
  10. miRNA expression profile in multicellular breast cancer spheroids
    Edna Ayerim Mandujano-Tinoco et al, 2017, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
  11. The Role of MicroRNAs in Mature B-Cell Neoplasias Drug Resistance
    Rui Bergantim et al, 2024, Reference Module in Biomedical Sciences CrossRef
  12. BCL6 BTB‐specific inhibition via FX1 treatment reduces Tfh cells and reverses lymphoid follicle hyperplasia in Indian rhesus macaque (Macaca mulatta)
    Yanhui Cai et al, 2020, Journal of Medical Primatology CrossRef
  13. miRNA-Based Therapies in B Cell Non-Hodgkin Lymphoma
    Teresa Fuertes et al, 2020, Trends in Immunology CrossRef
  14. Oncogenic and Tumor-Suppressive Roles of MicroRNAs with Special Reference to Apoptosis: Molecular Mechanisms and Therapeutic Potential
    Dharambir Kashyap et al, 2018, Molecular Diagnosis & Therapy CrossRef
  15. miRNA- and lncRNA-Based Therapeutics for Non-Hodgkin’s Lymphoma: Moving towards an RNA-Guided Precision Medicine
    Mara Fernandes et al, 2021, Cancers CrossRef
  16. Identification of novel miRNAs potentially involved in the pathogenesis of adult T-cell leukemia/lymphoma using WGCNA followed by RT-qPCR test of hub genes
    Ali Shayeghpour et al, 2023, Infectious Agents and Cancer CrossRef

  17. Non-Coding RNAs in Diffuse Large B-Cell Lymphoma


    Yan Shi et al, 2020, OncoTargets and Therapy CrossRef
  18. Downregulation of miR-10b promotes osteoblast differentiation through targeting Bcl6
    Jizhou Yang et al, 2017, International Journal of Molecular Medicine CrossRef
  19. miRNAs in B-cell lymphoma: Molecular mechanisms and biomarker potential
    Carla Solé et al, 2017, Cancer Letters CrossRef
  20. Noncoding RNAs in B cell non-Hodgkins lymphoma
    Zahra Abedi Kichi et al, 2024, Gene CrossRef
  21. Dysregulation of miRNAs in DLBCL: Causative Factor for Pathogenesis, Diagnosis and Prognosis
    Mohammed Alsaadi et al, 2021, Diagnostics CrossRef
  22. Down-regulated miR-148b increases resistance to CHOP in diffuse large B-cell lymphoma cells by rescuing Ezrin
    Ni Sun et al, 2018, Biomedicine & Pharmacotherapy CrossRef